BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 28579160)

  • 1. Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.
    De Jong KA; Lopaschuk GD
    Can J Cardiol; 2017 Jul; 33(7):860-871. PubMed ID: 28579160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction.
    Hahn VS; Petucci C; Kim MS; Bedi KC; Wang H; Mishra S; Koleini N; Yoo EJ; Margulies KB; Arany Z; Kelly DP; Kass DA; Sharma K
    Circulation; 2023 Apr; 147(15):1147-1161. PubMed ID: 36856044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
    Streng KW; Nauta JF; Hillege HL; Anker SD; Cleland JG; Dickstein K; Filippatos G; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Damman K; van der Meer P; Voors AA
    Int J Cardiol; 2018 Nov; 271():132-139. PubMed ID: 30482453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction.
    Fillmore N; Levasseur JL; Fukushima A; Wagg CS; Wang W; Dyck JRB; Lopaschuk GD
    Mol Med; 2018 Mar; 24(1):3. PubMed ID: 30134787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle alterations in HFrEF vs. HFpEF.
    Adams V; Linke A; Winzer E
    Curr Heart Fail Rep; 2017 Dec; 14(6):489-497. PubMed ID: 28940089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
    Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
    J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
    Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
    Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
    Paulus WJ; Dal Canto E
    JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
    van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
    Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
    Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.
    Mentz RJ; Kelly JP; von Lueder TG; Voors AA; Lam CS; Cowie MR; Kjeldsen K; Jankowska EA; Atar D; Butler J; Fiuzat M; Zannad F; Pitt B; O'Connor CM
    J Am Coll Cardiol; 2014 Dec; 64(21):2281-93. PubMed ID: 25456761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity-related heart failure with preserved ejection fraction: new treatment strategies.
    Chrysant SG; Chrysant GS
    Hosp Pract (1995); 2019 Apr; 47(2):67-72. PubMed ID: 30712418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Scherbakov N; Bauer M; Sandek A; Szabó T; Töpper A; Jankowska EA; Springer J; von Haehling S; Anker SD; Lainscak M; Engeli S; Düngen HD; Doehner W
    Eur J Heart Fail; 2015 Oct; 17(10):1015-21. PubMed ID: 26198713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction.
    Güven B; Sun Q; Wagg CS; Almeida de Oliveira A; Silver H; Persad KL; Onay-Besikci A; Vu J; Oudit GY; Lopaschuk GD
    J Pharmacol Exp Ther; 2024 Jan; 388(1):145-155. PubMed ID: 37977817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medications.
    Packer M
    Eur J Heart Fail; 2018 Jul; 20(7):1100-1105. PubMed ID: 29566300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure with preserved or reduced ejection fraction in patients treated with peritoneal dialysis.
    Wang AY; Wang M; Lam CW; Chan IH; Lui SF; Sanderson JE
    Am J Kidney Dis; 2013 Jun; 61(6):975-83. PubMed ID: 23474006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.